Wells Fargo & Company Ocugen, Inc. Transaction History

Wells Fargo & Company

$434 Billion
Q3 2024

A detailed history of Wells Fargo & Company transactions in Ocugen, Inc. stock. As of the latest transaction made, Wells Fargo & Company holds 86,838 shares of OCGN stock, worth $73,812. This represents 0.0% of its overall portfolio holdings.

Number of Shares

86,838

Previous 90,051 3.57%

Holding current value

$73,812

Previous $139,000 38.85%

% of portfolio

0.0%

Previous 0.0%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	SELL	$0.98 - $1.95 $3,148 - $6,265	-3,213 Reduced 3.57%	86,838 $85,000
Q2 2024 Aug 13, 2024	BUY	$1.18 - $1.98 $97,958 - $164,371	83,016 Added 1180.04%	90,051 $139,000
Q1 2024 May 10, 2024	SELL	$0.5 - $1.83 $1,909 - $6,986	-3,818 Reduced 35.18%	7,035 $11,000
Q4 2023 Feb 09, 2024	BUY	$0.36 - $0.57 $60 - $96	169 Added 1.58%	10,853 $6,000
Q3 2023 Nov 13, 2023	BUY	$0.4 - $0.62 $209 - $324	523 Added 5.15%	10,684 $4,000
Q2 2023 Aug 15, 2023	SELL	$0.45 - $0.88 $18,162 - $35,516	-40,360 Reduced 79.89%	10,161 $5,000
Q1 2023 May 12, 2023	BUY	$0.82 - $1.33 $34,457 - $55,887	42,021 Added 494.36%	50,521 $42,000
Q4 2022 Feb 13, 2023	SELL	$1.11 - $1.87 $18,382 - $30,969	-16,561 Reduced 66.08%	8,500 $11,000
Q3 2022 Nov 14, 2022	SELL	$1.75 - $3.1 $6,917 - $12,254	-3,953 Reduced 13.62%	25,061 $45,000
Q2 2022 Aug 12, 2022	SELL	$1.83 - $3.45 $188,380 - $355,143	-102,940 Reduced 78.01%	29,014 $66,000
Q1 2022 May 16, 2022	SELL	$2.34 - $4.72 $129,093 - $260,392	-55,168 Reduced 29.48%	131,954 $435,000
Q4 2021 Feb 14, 2022	BUY	$4.38 - $15.67 $115,759 - $414,142	26,429 Added 16.45%	187,122 $852,000
Q3 2021 Nov 15, 2021	BUY	$6.36 - $8.51 $925,233 - $1.24 Million	145,477 Added 956.08%	160,693 $1.15 Million
Q2 2021 Aug 16, 2021	BUY	$5.52 - $15.68 $51,319 - $145,776	9,297 Added 157.07%	15,216 $123,000
Q1 2021 May 13, 2021	BUY	$1.66 - $15.81 $604 - $5,754	364 Added 6.55%	5,919 $40,000
Q4 2020 Feb 09, 2021	BUY	$0.28 - $2.6 $1,323 - $12,290	4,727 Added 570.89%	5,555 $10,000
Q3 2020 Nov 05, 2020	BUY	$0.2 - $0.72 $122 - $440	612 Added 283.33%	828 $0
Q2 2020 Aug 13, 2020	BUY	$0.22 - $0.46 $0 - $0	2 Added 0.93%	216 $0
Q1 2020 May 14, 2020	BUY	$0.26 - $0.73 $55 - $156	214 New	214 $0

Others Institutions Holding OCGN

# of Institutions

124

Shares Held

78.3M

Call Options Held

535K

Put Options Held

523K

View Full List

About Ocugen, Inc.

Ticker OCGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 216,566,000
Market Cap $184M
Description
Ocugen, Inc., a clinical-stage biopharmaceutical company, focuses on the developing gene therapies to cure blindness diseases. The company's pipeline product includes OCU400, a novel gene therapy product candidate restoring retinal integrity and function across a range of genetically diverse inherited retinal diseases, such as retinitis pigmento...

More about OCGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Wells Fargo & Company, based on Form 13F filings with the SEC.

News

Stay updated on Wells Fargo & Company with notifications on news.

Account

Wells Fargo & Company Ocugen, Inc. Transaction History